Variant report
Variant | esv2034625 |
---|---|
Chromosome Location | chr3:161768909-161769333 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4340718 | chr3:161768924-161768925 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs74818975 | chr3:161768959-161768960 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs115264970 | chr3:161768966-161768967 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs576344837 | chr3:161768973-161768974 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs141036234 | chr3:161768997-161768998 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs76755745 | chr3:161769000-161769001 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs113525673 | chr3:161769008-161769009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs398062976 | chr3:161769012-161769013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs180808857 | chr3:161769036-161769037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs79408595 | chr3:161769037-161769038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs546246699 | chr3:161769041-161769042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs532396678 | chr3:161769056-161769057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs62278865 | chr3:161769057-161769058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs4611839 | chr3:161769064-161769065 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs577696515 | chr3:161769067-161769068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs62278866 | chr3:161769072-161769073 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs62278867 | chr3:161769083-161769084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs62278868 | chr3:161769085-161769086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs62278869 | chr3:161769089-161769090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs62278870 | chr3:161769097-161769098 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs185255084 | chr3:161769103-161769104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs148729312 | chr3:161769111-161769112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs562035222 | chr3:161769131-161769132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs531037264 | chr3:161769145-161769146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs71151760 | chr3:161769162-161769163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs545146363 | chr3:161769174-161769175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs563133472 | chr3:161769181-161769182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs6800261 | chr3:161769193-161769194 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs564667033 | chr3:161769203-161769204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs190022090 | chr3:161769233-161769234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs182648356 | chr3:161769234-161769235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs552200968 | chr3:161769235-161769236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs386667671 | chr3:161769251-161769252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs373047809 | chr3:161769252-161769253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs546557331 | chr3:161769272-161769273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs145058929 | chr3:161769309-161769310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs566135879 | chr3:161769313-161769314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs138902241 | chr3:161769314-161769315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs114152621 | chr3:161769321-161769322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Bladder cancer | 21909424 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:161766600-161771000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr3:161768000-161769000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |